US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist

0.5950
+0.0217+3.79%

Close Aug 23 16:00 ET

0.6000
+0.0050+0.84%

Post 20:02 ET

107.53MMarket Cap-2479P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

-16.95%-28.36M

-13.26%-6.33M

Net income from continuing operations

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-45.92%-33.64M

-61.07%-7.99M

Depreciation and amortization

7.82%52.85K

8.16%52.07K

8.10%51.01K

8.15%194.32K

8.04%49.97K

8.09%49.02K

8.26%48.14K

8.20%47.19K

8.98%179.68K

8.14%46.25K

Deferred tax

0.00%144K

0.00%576K

-75.00%144K

--144K

--576K

Other non cash items

--109.95K

--98.08K

--76.15K

-73.03%102K

--0

----

456.18%378.2K

--104.32K

Change In working capital

52.94%-1.16M

-315.48%-2.61M

91.10%-233.46K

-1,772.40%-4.01M

-180.37%-126.19K

-2,508.46%-2.47M

136.24%1.21M

-174.32%-2.62M

108.82%239.56K

95.35%-45.01K

-Change in prepaid assets

45.89%-1.08M

-183.52%-1.15M

100.97%25.01K

-4,430.59%-5.04M

8.15%-57.19K

-595.21%-2M

-2,083.45%-405.48K

-1,283.16%-2.58M

95.72%-111.18K

95.76%-62.26K

-Change in payables and accrued expense

39.55%-606.89K

-115.69%-377.13K

-10,541.30%-205.8K

23.99%832.86K

-35.15%-568.91K

-1,906.25%-1M

227.58%2.4M

-99.93%1.97K

421.06%671.72K

-336.95%-420.95K

-Change in other current liabilities

-10.93%-54.82K

-10.93%-53.74K

-10.92%-52.68K

-11.14%-196.99K

-10.93%-51.64K

-11.22%-49.42K

-11.22%-48.44K

-11.22%-47.49K

-11.47%-177.24K

-11.22%-46.55K

-Change in other working capital

-0.01%579.59K

----

374.60%394.73K

13.78%551.54K

19.70%579.67K

----

-157.25%-143.75K

32.38%484.75K

Cash from discontinued investing activities

Operating cash flow

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

-16.95%-28.36M

-13.26%-6.33M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

13.83M

-687

Net common stock issuance

----

--13.8M

---31.95K

----

--0

Proceeds from stock option exercised by employees

----

--31.27K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-0.58%13.72M

----

--13.83M

---687

--13.8M

----

--0

Net cash flow

Beginning cash position

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-40.47%41.71M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

405.59%70.07M

-58.46%48.04M

Current changes in cash

26.93%5.35M

0.46%-7.79M

-27.17%-6.14M

46.30%-15.23M

-7.40%-6.8M

154.67%4.22M

19.07%-7.82M

-3.72%-4.82M

-150.45%-28.36M

86.11%-6.33M

End cash Position

-46.18%17.91M

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

Free cash flow

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

55.86%-28.36M

86.11%-6.33M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	-16.95%-28.36M	-13.26%-6.33M
Net income from continuing operations	-24.70%-10.57M	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-45.92%-33.64M	-61.07%-7.99M
Depreciation and amortization	7.82%52.85K	8.16%52.07K	8.10%51.01K	8.15%194.32K	8.04%49.97K	8.09%49.02K	8.26%48.14K	8.20%47.19K	8.98%179.68K	8.14%46.25K
Deferred tax	0.00%144K	0.00%144K	0.00%144K	0.00%576K	-75.00%144K	--144K	--144K	--144K	--576K	--576K
Other non cash items	--109.95K	--98.08K	--76.15K	-73.03%102K	--0	--0	----	----	456.18%378.2K	--104.32K
Change In working capital	52.94%-1.16M	-315.48%-2.61M	91.10%-233.46K	-1,772.40%-4.01M	-180.37%-126.19K	-2,508.46%-2.47M	136.24%1.21M	-174.32%-2.62M	108.82%239.56K	95.35%-45.01K
-Change in prepaid assets	45.89%-1.08M	-183.52%-1.15M	100.97%25.01K	-4,430.59%-5.04M	8.15%-57.19K	-595.21%-2M	-2,083.45%-405.48K	-1,283.16%-2.58M	95.72%-111.18K	95.76%-62.26K
-Change in payables and accrued expense	39.55%-606.89K	-115.69%-377.13K	-10,541.30%-205.8K	23.99%832.86K	-35.15%-568.91K	-1,906.25%-1M	227.58%2.4M	-99.93%1.97K	421.06%671.72K	-336.95%-420.95K
-Change in other current liabilities	-10.93%-54.82K	-10.93%-53.74K	-10.92%-52.68K	-11.14%-196.99K	-10.93%-51.64K	-11.22%-49.42K	-11.22%-48.44K	-11.22%-47.49K	-11.47%-177.24K	-11.22%-46.55K
-Change in other working capital	-0.01%579.59K	----	----	374.60%394.73K	13.78%551.54K	19.70%579.67K	----	----	-157.25%-143.75K	32.38%484.75K
Cash from discontinued investing activities
Operating cash flow	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	-16.95%-28.36M	-13.26%-6.33M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities				13.83M	-687				0	0
Net common stock issuance	----	----	----	--13.8M	---31.95K	----	----	----	--0	--0
Proceeds from stock option exercised by employees	----	----	----	--31.27K	----	----	----	----	--0	----
Cash from discontinued financing activities
Financing cash flow	-0.58%13.72M	----	----	--13.83M	---687	--13.8M	----	----	--0	--0
Net cash flow
Beginning cash position	-56.79%12.56M	-44.84%20.35M	-36.51%26.48M	-40.47%41.71M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M	-40.47%41.71M	405.59%70.07M	-58.46%48.04M
Current changes in cash	26.93%5.35M	0.46%-7.79M	-27.17%-6.14M	46.30%-15.23M	-7.40%-6.8M	154.67%4.22M	19.07%-7.82M	-3.72%-4.82M	-150.45%-28.36M	86.11%-6.33M
End cash Position	-46.18%17.91M	-56.79%12.56M	-44.84%20.35M	-36.51%26.48M	-36.51%26.48M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M	-40.47%41.71M	-40.47%41.71M
Free cash flow	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	55.86%-28.36M	86.11%-6.33M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall